Enzymes involved in ceramide biosynthesis, dihydroceramide desaturase, (DES1) and ceramide synthase (CerS)-6 have been implicated with increased ceramide production mediating obesity associated metabolic dysregulation in mice and humans35. This evidence concerns the gene TLCD3B and obesity due to melanocortin 4 receptor deficiency.